Monotherapy With Rapamycin in Long-standing Type 1 Diabetes

NCT02803892 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: rapamycin
DRUG: Vildagliptin
DRUG: Placebo 1
DRUG: Placebo 2

Sponsor

Piemonti Lorenzo

Collaborators

[object Object]